Deaths Lead to Recall of NeutroSpec
Adverse Events Lead to Recall of NeutroSpec. Following the FDA’s request, Palatin Technologies Inc., the makers of NeutroSpec, an imaging agent used to diagnose appendicitis, are withdrawing the product from the market. There have been now been two deaths and 20 “serious and life-threatening” complications linked to the … [Read more...] about Deaths Lead to Recall of NeutroSpec
NeutroSpec Withdrawn From Market
NeutroSpec Withdrawn From Market. The Food and Drug Administration (FDA) has issued an alert about NeutroSpec, a diagnostic imaging agent injected into a patient's bloodstream to help doctors diagnose ailments, saying it may cause severe, life-threatening reactions in some people. The manufacturer, Palatin Technologies Inc. and … [Read more...] about NeutroSpec Withdrawn From Market
NeutroSpec Public Health Advisory
NeutroSpec Life-Threatening Adverse Events. The Food and Drug Administration (FDA) today issued a Public Health Advisory to alert health care providers that the agency has requested the market withdrawal of the diagnostic imaging agent NeutroSpec [Technetium (99m TC) Fanolesomab] pending review of reported deaths and … [Read more...] about NeutroSpec Public Health Advisory
